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Background: Tuberculosis (TB) poses a worldwide threat due to advancing multidrug-resistant strains and deadly
co-infections with Human immunodeficiency virus. Today large amounts of Mycobacterium tuberculosis whole
genome sequencing data are being assessed broadly and yet there exists no comprehensive online resource that
connects M. tuberculosis genome variants with geographic origin, with drug resistance or with clinical outcome.
Description: Here we describe a broadly inclusive unifying Genome-wide Mycobacterium tuberculosis Variation
(GMTV) database, (http://mtb.dobzhanskycenter.org) that catalogues genome variations of M. tuberculosis strains
collected across Russia. GMTV contains a broad spectrum of data derived from different sources and related to
M. tuberculosis molecular biology, epidemiology, TB clinical outcome, year and place of isolation, drug resistance
profiles and displays the variants across the genome using a dedicated genome browser. GMTV database, which
includes 1084 genomes and over 69,000 SNP or Indel variants, can be queried about M. tuberculosis genome
variation and putative associations with drug resistance, geographical origin, and clinical stages and outcomes.
Conclusions: Implementation of GMTV tracks the pattern of changes of M. tuberculosis strains in different
geographical areas, facilitates disease gene discoveries associated with drug resistance or different clinical sequelae,
and automates comparative genomic analyses among M. tuberculosis strains.
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DatabaseBackground
Tuberculosis (TB) remains an ongoing threat to world-
wide public health, which in 2011 caused some 8.7 new
cases and killed 1.4 million people, including 430,000
co-infected with Human immunodeficiency virus (HIV)
[1]. The incidence of multidrug-resistant strains is rising
in spite of increasing financial resources being released
to stem the epidemic. With globalization, improvement* Correspondence: echernya@gmail.com; lgdchief@gmail.com
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article, unless otherwise stated.of the health care and epidemic control systems in one
country may not guarantee prevention of this airborne
disease in others. Russia reported 180,000 TB cases and
20,000 TB deaths in 2011 and shows the highest inci-
dence of new multidrug-resistant strains developed largely
due to noncompliant drug regimens [1,2].
Molecular genetic studies of Mycobacterium tubercu-
losis strains using various genotyping technologies offer
an approach to monitor strain dispersal and evolutionary
adaptations, important to stem bacterial and disease
spread. Genetic markers that track TB transmission in-
clude IS6110, polymorphic GC-reach repetitive sequences,ntral Ltd. This is an Open Access article distributed under the terms of the
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petitive units [3-7]. Recently, it was shown that bacterial
whole genome sequencing (WGS) provides greater
discriminative power [8-11]. WGS of multiple isolates
may address a broad range of topics – from questions
on the transmission of clinical strains to how M. tu-
berculosis evolves over long and short time scales.
Rapid analysis of WGS data allows to detect bacterial
genetic variants based on single nucleotide polymor-
phisms (SNPs) and insertion/deletions (Indels), in-
cluding mutations associated with drug resistance or
genetic lineage.
Increasingly large quantities of genome sequence
data are becoming available from different types of
M. tuberculosis studies [12-16]. Numerous M. tuber-
culosis WGS studies have been used for phylogenetic
analyses and to identify genetic factors involved in
TB drug resistance [15,17,18]. Several databases were
developed to systematize and compare genomic data.
TubercuList (http://tuberculist.epfl.ch) database pro-
vides gene-based information of M. tuberculosis H37Rv
genome [19]. Tuberculosis Database (TBDB http://www.
tbdb.org) is an integrated database providing access to TB
genomic sequence data and resources from Mycobacter-
ium species and M. tuberculosis strains, relevant to the
discovery and development of TB drugs, vaccines and bio-
markers. Currently TBDB contains information about 21
mycobacterial species whole genome sequences, nine of
which belong to M. tuberculosis complex [20]. Mycobac-
terial Genome Divergence Database (MGDD), allows to
find genetic differences between two strains or species of
M. tuberculosis complex [21]. A web-based comprehen-
sive information system Pathosystems Resource Integra-
tion Center (PATRIC, http://patricbrc.org) provides
comparative analysis for genomes of different bacterial
pathogens, one of which is M. tuberculosis [22]. To date
PATRIC contains 201 mycobacterial isolates whole gen-
ome sequences, 68 of which are M. tuberculosis genomes.
Although these TB information databases have been
established, there is no comprehensive online resource
that brings together detailed information on M. tubercu-
losis genome variations associated with phylogeographic
distribution, drug resistance and clinical outcome of TB.
Here we describe and release a broadly inclusive unifying
database – Genome-wide Mycobacterium tuberculosis
Variation (GMTV) – that catalogues genome variations of
Russian M. tuberculosis strains combined with available
clinical data. GMTV helps to discover genomic variants of
M. tuberculosis strains from different geographical areas
and lists genetic markers associated with drug resistance
and different clinical TB signs. GMTV allows association
analysis between molecular variation and clinical conse-
quences as well as facilitating epidemiological surveillance
of TB and HIV/TB co-infection. Our hope is that thedatabase will allow to find efficacious strategies to control
TB infection and spread.
Construction and content
Database construction
GMTV database contains a broad spectrum of data de-
rived from different sources and relates to M. tuberculosis
molecular biology, epidemiology, TB clinical outcome,
year and place of isolation, and drug resistance profiles.
Access to GMTV database is distributed through web
application with Python backend that connected to
our MySQL database. Every record in the database is
identified by the unique sample ID. Each sample ID
corresponds to the set of SNPs and Indels and other
information (e.g. medical, geographical and drug resist-
ance data). The database includes information from fol-
lowing databases: NCBI, KEGG metabolic pathways
[23,24] and TubercuList [19], the web interface provides
access to the corresponding websites through hyperlinks.
The GMTV genome browser is an essential tool for gen-
ome variations visualization that could be used as an ana-
lytical tool to compare nucleotide variations. The core of
our MySQL database is manually curated and contain
M. tuberculosis genome sequences assessed at Theodosius
Dobzhansky Center for Genome Bioinformatics (St.
Petersburg), Research Institute of Physical-Chemical
Medicine (Moscow) and publicly available data of se-
quenced M. tuberculosis strains obtained in Russia.
Mycobacterium tuberculosis H37Rv reference genome
(NC_000962.3) was used for SNP and Indel calling. For
reference assisted assembly sequence reads were aligned
on reference genome (H37Rv) using bowtie2 program
[25] with standard parameters (bowtie2 -x H37Rv - p30 -U
raw_reads.fq -S aligned_reads.sam). For SNP calling and
VCF file processing a combination of samtools and vcftools
was used [26,27].
A web genome browser, GMTVB, based on JBrowse
platform [28,29] is an essential component of GMTV.
GMTVB allows one to compare distinct regions or genes
among M. tuberculosis strains, including an option to se-
lect a particular reference sequence, e.g. H37Rv. GMTVB
implements an AJAX paradigm, which increases reaction
time. Distinctive regions, genes, genomic features are dis-
played in tracks. Some tracks are permanent for the refe-
rence (e.g. genes, CDS, repeats, etc.). The interface allows
one to add, delete and substitute tracks as well as to
change reference sequences. GMTV clinical and gen-
etic data combined with graphical tools incorporated in
GMTVB makes the database an effective instrument for
TB analysis (available at http://mtb.dobzhanskycenter.org).
M. tuberculosis isolates and genome sequence
Whole genome sequences from 1084M. tuberculosis iso-
lates with various medical datasets from different regions
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The database contains information on 73 isolates se-
quenced by our research group and 1011 publicly avail-
able genome sequences.
Sequence data for 73M. tuberculosis strains were pro-
vided by Theodosius Dobzhansky Center for Genome
Bioinformatics (St. Petersburg State University) and Re-
search Institute of Physical-Chemical Medicine. These
M. tuberculosis strains were collected in St. Petersburg
(n = 47), Leningrad Oblast (n = 7), Moscow (n = 7),
Volgograd (n = 2), Kalmykiya (n = 2), Buryatya (n = 1),
Arkhangelsk Oblast (n = 1), Chelyabinsk Oblast (n = 1),
Kaliningrad Oblast (n = 1), Novgorod Oblast (n = 1),
Nizhniy Novgorod Oblast (n = 1), Ulyanovsk Oblast (n = 1)
and Zabaykalsky Krai (n = 1) (Figure 1). Bacterial isolates
were provided by Saint-Petersburg Research Institute of
Phthisiopulmonology (M. tuberculosis All-Russian Collec-
tion) and Moscow Scientific-Practical Center of Treatment
of Tuberculosis of Moscow Healthcare. Genomic DNA of
73M. tuberculosis strains was isolated using standard
extraction method [4]. DNA samples were used for li-
brary preparation and sequenced using Illumina MiSeq
Sequencing Platform and Roche 454 Life Sciences Gen-
ome Sequencer FLX following the manufacturer’s instruc-
tions. Sequencing data for M. tuberculosis sequenced
genomes were deposited in the NCBI Sequence Read
Archive [30] under accession numbers PRJNA218508 and
PRJNA181180. The accuracy of these data stored atFigure 1 Regions of the Russian Federation, from which M. tuberculos
genomes included into the database are highlighted with pink color.GMTV database is guaranteed by institutions that re-
vealed the disease, performed microbiological tests and
genomic data analysis (spoligotyping and WGS).
Whole genome sequence reads of other 1011 Russian
M. tuberculosis isolates obtained in Samara region (Russia)
were downloaded from the European Nucleotide Archive
(http://www.ebi.ac.uk/ena/) submitted under accession no.
ERP000192 [31,32]. The region of M. tuberculosis strains
isolation and available drug susceptibility tests results pro-
vided by the authors were deposited to GMTV database.
Information about microbiological drug susceptibility
tests is available for the majority of sequenced bacterial
strains. Medical data were not available for all samples,
however it will be updated as far as possible. To date
GMTV database contains information on eleven isolates
obtained from HIV-infected patients, 19 from HIV-
negative, the rest of isolates were collected from people
with unknown HIV status. Classical spoligotyping method
was performed for 61 sequenced bacterial isolates [35].
Following spoligotype families were identified according
to SpolDB4 database: Beijing (n = 38), H4 (n = 12), LAM9
(n = 9), T1 (n = 2) (Figure 2). Based on SNP analysis de-
scribed earlier [16] we identified following genetic lineages
among 1084M. tuberculosis genomes: Beijing (n = 685),
New/Uganda/X-type/not defined (n = 135), Ural (n = 111),
LAM (n = 96), Haarlem (n = 40), S-type (n = 4), Dehli/
CAS (n = 3), Not defined (n = 10) (Figure 2). Spoligo-
type International Type (SIT) number could be usedis isolates were obtained. Source regions of M. tuberculosis strains
Figure 2 Genotypes of M. tuberculosis isolates included into GMTV database. Spoligotypes were identified using conventional spacer
oligonucleotide typing technique and genetic clades were identified using SNP analysis.
Table 1 Genome variants (SNPs and Indels) in GMTV
database filtered by Q30
Genome variation SNPs Indels
Overall quantity 45655 23975
In CDS 39808 18537
Nonsynonymous mutations in CDS 24124 -
Synonymous mutations in CDS 13392 -
Variations in STOP-codons in CDS 684 -
Frameshift mutations in CDS - 10993
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outcome of the TB was known for 30 isolates: 12 iso-
lates were collected from patients with extrapulmon-
ary TB, 15 from patients with pulmonary TB and 3
from patients with both pulmonary and extrapulmon-
ary localizations. Four hundred eighty-seven isolates had
proved multiple drug resistance (MDR) and 60 Extensive
Drug Resistance (XDR). Limiting clinical data represented
in the database without patient identifiers protects pa-
tients’ privacy.
Utility and discussion
The current version of GMTV database has a web inter-
face for the retrieval of genomic diversity, geography,
drug resistance and clinical information. A derived gen-
ome variation table contains several types of information:
1. Sample: Sample ID, HIV status of the patient,
patients’ gender, ear of strain isolation, spoligotype
family name based on SpolDB4 [33], genetic clades
based on SNP analysis [16], and geographical region.
2. Genes: Gene ID on NCBI database, gene name,
locus tag, coordinates of gene start and end.
3. Variations (SNPs and Indels): SNP/Indel
coordinates, Nucleic acid variations, Amino acid
substitutions, Effect of the nucleic acid substitution
(synonymous or nonsynonymous), various VCF file
statistics, The SNP/Indels sections allows to
download VCF file and easily get appropriate
annotation of genome variations results. SNP, Indel
or SNP/Indel options could be selected.
4. Databases: Information about protein function and
protein functional category, according to
TubercuList database [19] and Metabolic pathways,
according to the KEGG database [23,24].
The input file for the database is a VCF file and a
FASTQ file of the assembled genome, which can be down-
loaded from the website. Presently the GMTV databasecontains 1084 genomes and over 45,000 SNPs and 23,000
Indel variants across whole genomes with Quality (Q)
score 30 threshold (Table 1). The Q score is one of the
VCF file statistics associated with the probability of each
substitution. The Q30 threshold means that the probabil-
ity of incorrect base substitution is 1 in 1000. More than
half of SNPs in coding regions (64%) are nonsynonymous.
Analysis of Indels size, derived from VCF files, showed
that one- and nine-nucleotide Indels are the most com-
mon, but other Indels are also widely spread (Figure 3).
The GMTV web interface contains detailed informa-
tion about genomic variations revealed from WGS data
and provides for convenient analysis of genomic vari-
ation to facilitate searches of disease associations. Cur-
rently GMTV database allows:
 Review SNPs and Indels of M. tuberculosis isolates
filtered by quality score and sequence coverage
selected by the user;
 Identify functions and related metabolic pathways of
genes where genome variations were identified using
the links to KEGG and TubercuList databases;
 Compare SNPs between several isolates selected by
drug resistance, clinical outcome, geographical
distribution, genetic lineage and other
characteristics. It is possible to select all, common or
unique genome variations, synonymous and
nonsynonymous mutations are highlighted;
Figure 3 Size distribution of Indels in M. tuberculosis genome. (A) Indels distribution without Quality threshold, (B) Indels distribution with
Quality threshold 30. One- and nine-nucleotide size Indels are the most common among M. tuberculosis isolates in GMTV database.
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tool, download a table with annotated genome
variations in CSV (Comma Separated Values) format
for further research, and visualize results with the
genome browser.
 Download VCF files with nucleotide genome
variations, FQ files with reference-assisted
assemblies of MTB genomes and FASTA files with
sequences of selected genes.
The work with the database starts from “Genome vari-
ations” page. To get required information the user can
select a sample or some features (e.g. drug resistance,
medical or genetic features) and click “Table” on the left
bottom of the page. After generating the result, the user
selects the type of information to be displayed in the top
section of the page (Figure 4). There are five types of
information which could be selected by the user: “sam-
ple info” provides medical, genetic and geographical in-
formation; “gene info” provides information about genes;
“SNP/Indel info” provides statistics from VCF files;
“Tuberculist database” provides information about genes
functions; “Metabolic Pathways Info” provides available
information from KEGG database. Information repre-
sented in the generated table could be filtered by sampleID, nucleotide position, gene name, geographical region
etc. SNPs and Indels are analyzed in separate tables; the
type of nucleotide variations could be selected in the top
left section. It is possible to compare genome variations of
bacterial isolates by downloading tables with mutations
found in each group of genomes. The user may compare
mutations in selected genes by listing several genes sepa-
rated with “;” on the “Select genome region” section. This
feature allows detecting mutations associated with drug
resistance as well as finding compensatory mutations in
other genes.
The “Download page” allows one to select some char-
acteristics of M. tuberculosis isolates or ID of the inter-
ested isolates and to generate a table with information
about genotype, geographic region and drug resistance.
Each genome could be downloaded as a VCF file repre-
senting genome variations, or as an FQ file representing
reference-assisted assembly of the genome. It is also pos-
sible to download FASTA files with a specific gene or
genes, for this purpose the user have to select a special
point “Gene” at the “Select genome region” section on
the left bar region of the page and list one or several
genes separated with ‘;’. This function is useful for com-
parative studies, for example, it allows analyzing selected
protein-coding genes without intergenic regions.
Figure 4 An output of a query (SNP). Query was based on SNPs in M. tuberculosis isolates with streptomycin and isoniazid resistance in coding
regions with Quality threshold 30.
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pare single nucleotide genome variations. It is possible
to browse variations in the whole genome sequence or
gene-by-gene in selected M. tuberculosis isolates. For
comparative analysis the user selects the sample ID in
the left bar (the number is not limited) or to select
interested features (medical, geographical, genotype or
drug resistance). User may set Q score and coverage
for SNPs. Generated table displays nucleotide varia-
tions and their position. It is possible to download the
whole table or to browse mutations at the genome
browser.
The combination of the database with a genome brow-
ser makes the GMTV an effective tool for interactive
analysis and research. The browser illustrates a scalable
map feature of the genome in tracks representing a site’s
position, strand, value and supplement notes. Perman-
ent tracks are preloaded into the browser (e.g. original
DNA sequence, genes, repeats, etc. as well as defined
SNPs, Indels) and listed on the left side of the screen.
Tracks may be hidden or shown and there is an op-
tion to form tracks ad hoc based on SQL request.
Such ad hoc tracks are created temporarily to provide
opportunities to analyze the combination of data in
visual form. Entire tracks can be downloaded in FASTA
format. Scalable views of the genome elements inside
the GMTVB let a user look at genome picture bothwith bird’s eye and as a detailed representation on
the DNA level. GMTVB allows one to compare gen-
omic features or to download selected feature for fur-
ther analysis.
GMTV database is designed to assist in identification
of genetic variants associated with drug resistance, clin-
ical outcome or geographic distribution of the pathogen.
It allows comparing nucleotide variations based on
WGS data in different groups of M. tuberculosis isolates.
Bacterial isolates could be divided into categories based
on their geographic origin, drug resistance pattern, gen-
etic clade or medical data. GMTV database functions
allow using for phylogeographic, epidemiological and
evolutionary studies.
GMTV is the first M. tuberculosis database to in-
tegrate clinical, epidemiological and microbiological
description with genome variations based on whole
genome sequencing data, a part of the large epi-
demiological database established at St. Petersburg
Research Institute of Phthisiopulmonology. The de-
velopment of a M. tuberculosis genome variations
database will allow empirical exploring of influences
of SNP and Indels around clinical outcomes. GMTV
will facilitate the epidemiological surveillance of TB
and HIV/TB co-infection and will help to develop
effective strategies to control these infections in the
population.
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GMTV allows association analysis between molecular
variation and clinical consequences as well as facili-
tates epidemiological surveillance of TB and HIV/TB
co-infection. Our hope is to inform efficacious strategies
for TB control.
Availability and requirements
The web server can be accessed at http://mtb.dobzhans-
kycenter.org.
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